☆ 4.7 Article

α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy

Ichiro Kawahata et al.

Summary: An aging society leads to an increased number of patients with cognitive and movement disorders. This review focuses on the role of FABP3, dopamine receptors, and other FABP family proteins in the process of alpha-synuclein propagation and the subsequent aggregate-induced cytotoxicity, and proposes the potential of FABP as a therapeutic target for alpha-synucleinopathies.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress

An Cheng et al.

Summary: The study demonstrates that FABP7 triggers alpha-synuclein oligomerization through oxidative stress, while FABP7 ligand 6 can inhibit FABP7-induced Syn oligomerization and aggregation, thereby rescuing glial cells and oligodendrocytes from cell death.

ACTA PHARMACOLOGICA SINICA (2022)

Add to Collection

Article Clinical Neurology

Characterization of a Novel Monoclonal Antibody for Serine-129 Phosphorylated alpha-Synuclein: A Potential Application for Clinical and Basic Research

Weijin Liu et al.

Summary: A specific p-alpha-syn detection tool has been developed in this study, which can play a role in studying the pathophysiological mechanisms of alpha-synuclein and has significant implications.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies

Ichiro Kawahata et al.

Summary: alpha-Synuclein is a protein associated with Parkinson's disease, and its phosphorylation and aggregation play a crucial role in disease pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Cell Biology

Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches

Marija Vidovic et al.

Summary: Parkinson's disease (PD) is the second-most common neurodegenerative disorder and lacks disease-modifying therapy. Aggregation of alpha-synuclein (alpha-Syn) is closely associated with PD, and current therapeutic strategies primarily focus on targeting alpha-Syn using small molecules and peptides. Other approaches such as gene silencing, cell transplantation, and immunotherapy are also being explored.

CELLS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets

Qingyun Guo et al.

Summary: Stroke is a leading cause of death and disability worldwide, but effective neuroprotective therapies for ischemic stroke patients are lacking. Lipids play important roles in the pathogenesis of neurological diseases, and fatty acid-binding proteins (FABPs) have been found to be involved in neurodegenerative diseases. However, FABPs' roles in ischemic stroke have received comparatively little attention. In this review, we summarize the literature on the associations between FABPs and ischemia and propose potential therapeutic targets for ischemic stroke.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice

Dian Yuan et al.

Summary: SAK3, like donepezil, shows significant effects in improving cognitive and emotional behaviors, as well as reducing oxidative stress levels in OBX mice. The antioxidative effects of SAK3 are similar to those of donepezil, suggesting they are among the neuroprotective mechanisms in AD pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Neurosciences

Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice

Wenbin Jia et al.

Summary: The study demonstrates that impaired D2R signaling due to lack of FABP3 may affect D1R and c-Fos signaling, leading to suppressed nicotine-induced CPP behaviors.

MOLECULAR NEUROBIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons

Ichiro Kawahata et al.

Summary: The study showed that dopamine D-2L receptors combined with FABP3 play a critical role in the uptake of alpha-synuclein by dopaminergic neurons. This finding suggests a novel pathogenic mechanism for synucleinopathies, including Parkinson's disease.

BIOMEDICINES (2021)

Add to Collection

Review Neurosciences

Neuropathology and molecular diagnosis of Synucleinopathies

Shunsuke Koga et al.

Summary: Synucleinopathies are a group of diseases characterized by pathological aggregates of alpha-synuclein in neurons and glia. The two main disease entities are Lewy body disease and multiple system atrophy, each with different clinical subtypes. Currently, there are no disease-modifying therapies, but research on molecular mechanisms provides hope for future treatments.

MOLECULAR NEURODEGENERATION (2021)

Add to Collection

Article Clinical Neurology

α-Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC-SNCA Mice

Norihito Uemura et al.

Summary: This study aimed to investigate the clinicopathological contribution of alpha-Syn spread from the olfactory bulb in PD. The results showed that alpha-Syn preformed fibril injections induced more widespread pathology in transgenic mice, affecting the olfactory pathway and limbic system, leading to hyposmia, anxiety, and memory loss.

MOVEMENT DISORDERS (2021)

Add to Collection

Article Neurosciences

Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2

Kazunori Sano et al.

Summary: The phosphorylation of alpha synuclein at Y136 in the Lewy body dementia brain is mediated by the unexpected kinase activity of CK2. CK2 can promote aggregate formation of r-alpha Syn with phosphorylation at S129 and Y136, while its inhibition attenuates the formation of aggregates with S129 phosphorylation and unexpectedly increases phosphorylation at Y136.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Add to Collection

Article Neurosciences

α-Synuclein aggregation in the olfactory bulb induces olfactory deficits by perturbing granule cells and granular-mitral synaptic transmission

Fengjiao Chen et al.

Summary: The aggregation of alpha-synuclein in the olfactory bulb can impair odor detection and perception in mice, as well as increase the activity of M/Ts cells. This study provides direct evidence of the impact of alpha-synuclein aggregates on olfactory dysfunction in Parkinson's disease and reveals the neural circuit mechanisms involved.

NPJ PARKINSONS DISEASE (2021)

Add to Collection

Article Geriatrics & Gerontology

Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies

Hideki Oizumi et al.

Summary: The study found that FABP3 protein is expressed in various neurons in human brain tissues, and is colocalized with alpha Syn aggregates in the brains of individuals with synucleinopathies but not with amyloid beta or p-tau aggregates in the brains of individuals with AD. Additionally, FABP3 was not present in p-alpha Syn deposits in biopsied skin tissues from individuals with PD.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice

Qingyun Guo et al.

Summary: The study demonstrates that FABPs may exacerbate infarct volumes after ischemic stroke, and inhibiting FABPs can alleviate ischemic injury. MF6 inhibits FABPs and reduces inflammation-associated prostaglandin E-2 levels, potentially serving as a neuroprotective therapy for ischemic stroke.

BIOMEDICINES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy

An Cheng et al.

Summary: Synucleinopathies are a group of diverse diseases that can cause motor and cognitive dysfunction due to progressive neuronal loss or demyelination, often found in diseases like Parkinson's and dementia with Lewy bodies. Mitochondrial injury plays a crucial role in neuronal loss and oligodendrocyte dysfunction in these neurodegenerative disorders, with alpha-synuclein accumulation in the mitochondrial membrane being a key factor.

BIOMEDICINES (2021)

Add to Collection

Article Neurosciences

Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice

Kazuya Matsuo et al.

Summary: This study demonstrates the crucial role of fatty acid-binding protein 3 (FABP3) in pathogenic alpha-synuclein accumulation and its seeding ability, showing that the deletion of FABP3 can reduce the accumulation of exogenous alpha-synuclein in the substantia nigra pars compacta and attenuate motor impairments. These results suggest that FABP3 could be a potential therapeutic target against alpha-synuclein propagation in synucleinopathies.

BRAIN RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

T-Type Ca2+ Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model

Jing Xu et al.

Summary: SAK3 activates CaMKII to enhance proteasomal activity, leading to the degradation of α-Syn and slowing down the progression of LBD. This study reveals the promoting effect of SAK3 on α-Syn pathology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Neurosciences

A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model

Nicole K. Polinski

Summary: The use of wildtype recombinant alpha-synuclein preformed fibrils for generating a rodent model of PD is a popular approach for studying the disease biology and testing therapeutic strategies, showcasing strengths in recapitulating key features of PD pathogenesis. Despite its widespread use, variability in observed phenotypes exists, highlighting the need for careful study design and characterization.

JOURNAL OF PARKINSONS DISEASE (2021)

Add to Collection

Review Chemistry, Multidisciplinary

α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques

Nicolo Bisi et al.

Summary: Alpha-synuclein is a highly expressed and conserved protein found in neuronal presynaptic terminals, and its misfolding and aggregation are associated with several neurodegenerative diseases. Studies have shown that the structure of alpha-synuclein can be influenced by various factors, including mutations, biological environment, and interactions with exogenous compounds.

FRONTIERS IN CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3

Naoya Fukui et al.

Summary: The study found that the binding of FABP3 protein to αSyn protein alters the aggregation mechanism of αSyn, enhancing its cytotoxicity towards cells, and can be disrupted by αSynP130-140. This discovery may help prevent the accumulation of toxic FABP3-αSyn oligomers in cells, thereby halting the progression of Parkinson's disease.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain

Yasushi Yabuki et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia

Ichiro Kawahata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The emerging role of ?-synuclein truncation in aggregation and disease

Zachary A. Sorrentino et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Add to Collection

Article Pharmacology & Pharmacy

Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands

Yasuharu Shinoda et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)

Add to Collection

Review Pharmacology & Pharmacy

Modeling Parkinson's Disease With the Alpha-Synuclein Protein

Monica Gomez-Benito et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Article Behavioral Sciences

Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice

Hidaka Haga et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)

Add to Collection

Article Neurosciences

Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice

Kazuya Matsuo et al.

NEUROPHARMACOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations

Anvesh K. R. Dasari et al.

BIOCHEMISTRY (2019)

Add to Collection

Review Neurosciences

Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications

Natalia P. Alza et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Add to Collection

Review Neurosciences

α-synuclein in the pathophysiology of Alzheimer's disease

Daniel Twohig et al.

MOLECULAR NEURODEGENERATION (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP+-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons

Ichiro Kawahata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Neurosciences

α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb

Nolwen L. Rey et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Add to Collection

Review Clinical Neurology

Modeling α-Synuclein Propagation with Preformed Fibril Infections

Hyun Kyung Chung et al.

JOURNAL OF MOVEMENT DISORDERS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Determinants of dopaminergic neuron loss in Parkinson's disease

Dalton James Surmeier

FEBS JOURNAL (2018)

Add to Collection

Review Biochemistry & Molecular Biology

alpha-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration

Chiara Fecchio et al.

MOLECULES (2018)

Add to Collection

Article Neurosciences

The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases

Nolwen L. Rey et al.

NEUROBIOLOGY OF DISEASE (2018)

Add to Collection

Article Chemistry, Multidisciplinary

C-terminal truncation of alpha-synuclein promotes amyloid fibril amplification at physiological pH

Ingrid M. van der Wateren et al.

CHEMICAL SCIENCE (2018)

Add to Collection

Article Multidisciplinary Sciences

C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction

Janin Lautenschlager et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions

Zachary A. Sorrentino et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Add to Collection

Article Clinical Neurology

Spread of aggregates after olfactory bulb injection of alpha-synuclein fibrils is associated with early neuronal loss and is reduced long term

Nolwen L. Rey et al.

ACTA NEUROPATHOLOGICA (2018)

Add to Collection

Meeting Abstract Clinical Neurology

FABP3 promotes α-synuclein oligomerization in parkinson's disease

K. Fukunaga et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Add to Collection

Review Neurosciences

Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff

Heiko Braak et al.

JOURNAL OF PARKINSONS DISEASE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils

Matthew Redmann et al.

REDOX BIOLOGY (2017)

Add to Collection

Article Neurosciences

Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates

Shigeki Arawaka et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Steady-State Kinetics of a-Synuclein Ferrireductase Activity Identifies the Catalytically Competent Species

Jennifer S. McDowall et al.

BIOCHEMISTRY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization

Filsy Samuel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Add to Collection

Article Immunology

Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease

Nolwen L. Rey et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Add to Collection

Review Clinical Neurology

Review: Sporadic Parkinson's disease: development and distribution of -synuclein pathology

K. Del Tredici et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease

Yan Xu et al.

JOURNAL OF NEUROCHEMISTRY (2015)

Add to Collection

Article Multidisciplinary Sciences

Cysteine cathepsins are essential in lysosomal degradation of α-synuclein

Ryan P. McGlinchey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Add to Collection

Review Microbiology

Pathogens Penetrating the Central Nervous System: Infection Pathways and the Cellular and Molecular Mechanisms of Invasion

Samantha J. Dando et al.

CLINICAL MICROBIOLOGY REVIEWS (2014)

Add to Collection

Article Biochemistry & Molecular Biology

FABP3 Protein Promotes α-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity

Norifumi Shioda et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Add to Collection

Article Neurosciences

NOBILETIN TREATMENT IMPROVES MOTOR AND COGNITIVE DEFICITS SEEN IN MPTP-INDUCED PARKINSON MODEL MICE

Y. Yabuki et al.

NEUROSCIENCE (2014)

Add to Collection

Article Neurosciences

Expression pattern and localization of alpha-synuclein in the human enteric nervous system

Martina Boettner et al.

NEUROBIOLOGY OF DISEASE (2012)

Add to Collection

Article Medicine, Research & Experimental

α-Synuclein in Parkinson's Disease

Leonidas Stefanis

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Add to Collection

Article Behavioral Sciences

Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein

Yasutaka Izawa et al.

BRAIN AND BEHAVIOR (2012)

Add to Collection

Article Neurosciences

Heart-Type Fatty Acid Binding Protein Regulates Dopamine D2 Receptor Function in Mouse Brain

Norifumi Shioda et al.

JOURNAL OF NEUROSCIENCE (2010)

Add to Collection

Article Behavioral Sciences

Parkinson's Disease The Dual Hit Theory Revisited

Christopher H. Hawkes et al.

INTERNATIONAL SYMPOSIUM ON OLFACTION AND TASTE (2009)

Add to Collection

Article Pathology

Polyunsaturated fatty acids induce α-synuclein-related pathogenic changes in neuronal cells

Karen Assayag et al.

AMERICAN JOURNAL OF PATHOLOGY (2007)

Add to Collection

Review Clinical Neurology

Parkinson's disease: a dual-hit hypothesis

C. H. Hawkes et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.